Capricor Therapeutics, Inc. (CAPR) Q1 2025 Earnings Conference Call Transcript

Core Viewpoint - Capricor Therapeutics is conducting its Q1 2025 earnings conference call, indicating ongoing engagement with investors and stakeholders regarding its financial performance and future plans [1]. Group 1: Company Overview - The conference call features key participants including the Chief Financial Officer A.J. Bergmann and Chief Executive Officer Linda Marban, highlighting the leadership's involvement in communicating with investors [1]. - The call is structured to include a presentation followed by a question-and-answer session, suggesting a transparent approach to investor relations [1]. Group 2: Forward-Looking Statements - The CFO, A.J. Bergmann, emphasizes that forward-looking statements will be made regarding various aspects such as product efficacy, safety, R&D plans, clinical study timelines, and regulatory developments [3]. - These statements are based on current information and assumptions, which are subject to change due to risks and uncertainties that could lead to actual results differing from projections [4].